Systemic epidermal growth factor receptor-targeted sodium iodide symporter (NIS) gene therapy in a genetically engineered mouse model of pancreatic ductal adenocarcinoma Conference

Gruenwald, GK, Trajkovic-Arsic, M, Klutz, K et al. (2013). Systemic epidermal growth factor receptor-targeted sodium iodide symporter (NIS) gene therapy in a genetically engineered mouse model of pancreatic ductal adenocarcinoma . Human Gene Therapy, 24(12), A158-A158.

cited authors

  • Gruenwald, GK; Trajkovic-Arsic, M; Klutz, K; Gupta, A; Schwenk, N; Knoop, K; Braren, R; Settles, M; Senekowitsch-Schmidtke, R; Schwaiger, M; Wagner, E; Goeke, B; Ogris, M; Sievke, J; Spitzweg, C

authors

date/time interval

  • October 25, 2013 -

publication date

  • December 1, 2013

published in

keywords

  • Biotechnology & Applied Microbiology
  • Genetics & Heredity
  • Life Sciences & Biomedicine
  • Medicine, Research & Experimental
  • Research & Experimental Medicine
  • Science & Technology

start page

  • A158

end page

  • A158

volume

  • 24

issue

  • 12